Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE

Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE

Background: In the phase III SYNAPSE study, mepolizumab plus standard of care reduced total endoscopic nasal polyp score (NPS) versus that with placebo in patients with chronic rhinosinusitis with nasal polyps. Objective: Our aim was to investigate relationships between NPS and (1) peak nasal inspir...

Full description

Saved in:
Bibliographic Details
Main Authors: Amber U. Luong, MD, PhD, Joshua M. Levy, MD, MPH, MSc, Ludger Klimek, MD, PhD, Richard J. Harvey, MD, Jared Silver, MD, PhD, Steven G. Smith, PhD, Abby Fuller, MSc, Robert Chan, MD, Peter W. Hellings, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Chronic rhinosinusitis with nasal polyps
nasal polyp score
patient-reported outcomes
peak nasal inspiratory flow
mepolizumab
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829324001231
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772829324001231

Similar Items